Autopsy report · NCT04170959

The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC

“Loss of external funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months after it had already started.
• Ran for about 2 years 5 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

ethisch.comite@uza.be

Sponsor type

University, hospital or other

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Metformin; No metformin

Participants

3

Sites

1

Countries

Belgium

Trials that died the same way

• Idealizing Pregnancy Outcome With Single Blastocyst Transfer in a FET Cycle
  “loss of funding” (87% match in meaning)
• Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
  “Funding loss” (85% match in meaning)
• Meru Health Program to Treat Depression in Primary Care
  “Loss of grant funding.” (79% match in meaning)
• Effects of Vigabatrin on Cocaine Self-Administration
  “Funding ran out” (76% match in meaning)
• Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery
  “Ran out of funding” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.